Keros Therapeutics Inc
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
KROS$9.17-2.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| DECEMBER 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $559,931 | $331,147 |
| Accounts receivable | 2,742 | 143 |
| Prepaid expenses and other current assets | 26,220 | 16,003 |
| Total current assets | 588,893 | 347,293 |
| Operating lease right-of-use assets | 19,251 | 15,334 |
| Property and equipment, net | 4,237 | 4,134 |
| Restricted cash | 1,449 | 1,212 |
| Other long term assets | 2,056 | 2,052 |
| TOTAL ASSETS | $615,886 | $370,025 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable | $4,602 | $5,450 |
| Current portion of operating lease liabilities | 1,978 | 1,005 |
| Accrued expenses and other current liabilities | 20,870 | 17,918 |
| Total current liabilities | 27,450 | 24,373 |
| Operating lease liabilities, net of current portion | 16,883 | 13,439 |
| Total liabilities | 44,333 | 37,812 |
| COMMITMENTS AND CONTINGENCIES (Note 11) | ||
| STOCKHOLDERS’ EQUITY: | ||
| Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized as of December 31, 2024 and December 31, 2023; no shares issued and outstanding | — | — |
| Common stock, par value of $0.0001 per share; 200,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 40,554,705 and 31,841,084 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively | 4 | 3 |
| Additional paid-in capital | 1,140,328 | 713,636 |
| Accumulated deficit | (568,779) | (381,426) |
| Total stockholders’ equity | 571,553 | 332,213 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $615,886 | $370,025 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.